Bruce Feinberg, DO; Brian Kiss, MD; and Michael Kolodziej, MD, discuss challenges and opportunities for better utilizing palliative care to reduce cost and improve quality of care in oncology.
Dr Feinberg notes that currently, only half of appropriate patients receive hospice care, and the average length of stay is 7 days. Dr Feinberg asks Drs Kiss and Kolodziej to discuss ways to improve the utilization of palliative care.
Current guidelines suggest that doctors initiate discussions about palliative care with patients and patients’ loved ones when cancer has advanced or patients begin to have intractable pain, Dr Kiss explains. For this reason, palliative care is often not discussed until late in a patient’s disease course. Dr Kiss suggests that initiating conversations about palliative care early-on is key.
Dr Kolodziej describes the importance of adequate education and training in palliative care in oncology. He explains that discussing palliative care or end-of-life care with patients is among the most difficult of tasks for an oncologist. He notes that historically, there hasn’t been enough focus on educating and training oncologists regarding palliative care.
Another challenge, the result of a lack of palliative care training, is that many terms related to palliative care are misunderstood, adds Dr Kolodziej. Oncologists, he says, need to understand how to differentiate between palliative care, end-of-life care, and hospice care.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More